Latest News

Shenyang Research Institute Selects Provantis Preclinical Software Solution for Chinese Drug Safety Evaluation Center

Prestigious Chinese Research Institute Deploying Provantis SaaS to Increase Efficiencies and Further Streamline Preclinical Processes

CONSHOHOCKEN, PA – May 24, 2016 - Instem, a leading provider of IT solutions to the global early development healthcare market, announced today that the Shenyang Research Institute of Chemical Industry (SYRICI) has purchased the Provantis® preclinical software solution suite to manage preclinical processes at its National Center for New Drug Safety Evaluation, Shenyang, China (SYRICI CEC).


Instem Showcasing Study Management and Genetic Toxicology Solutions at International Toxicology and Safety Evaluation Workshop

May 6, 2016 - Instem Sponsors the NCDSER Workshop and Study Director Course in Shanghai


Instem Presenting at SEND Workshop

May 3, 2016 - Instem, Leading Pharmaceutical Organizations and Regulators to lead discussions on SEND Submission Expectations


Instem Presents at CDISC Europe Interchange

May 2, 2016 - Instem Discusses Key Differentiators Between Preclinical and Clinical Electronic Study Data Submissions


Instem Participates in SEND Panel Program Sponsored by the Pistoia Alliance

March 17, 2016 - Pistoia Alliance Debates Webinar Reviewing Key Principles of FDA-Adopted CDISC Preclinical Standard


View all news

Upcoming Events

Society of Toxicologic Pathology 35th Annual Symposium

June 26 - 30, 2016

San Diego, CA

Booth 200

Visit Conference Site


The 6th National Congress of Toxicology of CSOT

June 28 - July 1, 2016

Chongqing City, China

Booth C3

Visit Conference Site


43rd Annual Meeting of the Japanese Society of Toxicology

June 29 - July 1, 2016

Nagoya, Japan

Booth 84

Visit Conference Site

View all events